INFORMATION TO USERS
This manuscript has been reproduced from the microfilm master. UMI films the text directly fi'om the original or copy submitted. Thus, some thesis and dissertation copies are in typewriter face, while others may be fi'om any type of computer printer.
The quality of this reproduction is dependent upon the quality of the copy submitted. Broken or indistinct print, colored or poor quality illustrations and photographs, print bleedthrough, substandard margins, and improper alignment can adversely affect reproduction.
In the unlikely event that the author did not send UMI a complete manuscript and there are missing pages, these will be noted. Also, if unauthorized copyright material had to be removed, a note will indicate the deletion.
Oversize materials (e.g., maps, drawings, charts) are reproduced by sectioning the original, beginning at the upper left-hand comer and continuing fi’om left to right in equal sections with small overlaps. Each original is also photographed in one exposure and is included in reduced form at the back of the book.
Photographs included in the original manuscript have been reproduced xerographically in this copy. Higher quality 6” x 9” black and white photographic prints are available for any photographs or illustrations appearing in this copy for an additional charge. Contact UMI directly to order. UMI A Beil & Howell Information Company 300 North Zed) Road, Ann Arbor MI 48106-1346 USA 313/761-4700 800/521-0600
THE SUBCELLULAR DISTRIBUTION OF RAT LIVER AND YEAST
GLUCOSE-6-PHOSPHATE DEHYDROGENASE
AND ITS ROLE IN REGULATION OF THE ENZYME
DISSERTATION
Presented in Partial Fulfillment of the Requirement for
the Degree Doctor of Philosophy in the Graduate
School of The Ohio State University
By
Karen Elizabeth Reilly, B.S.
*****
The Ohio State University 1997
Dissertation Committee; Approved by John B. Allred, Advisor
Sylvia A. McCune Advisor Karla L. Roehrig Graduate Program in Food Science and Nutrition UMI Number: 9813339
UMI Microform 9813339 Copyright 1998, by UMI Company. All rights reserved.
This microform edition is protected against unauthorized copying under Title 17, United States Code.
UMI 300 North Zeeb Road Ann Arbor, MI 48103 ABSTRACT
GIucose-6-phosphate dehydrogenase (G6PD) belongs to the group of lipogenic
enzymes that all react similarly under lipogenic conditions. Specifically, when fasted
rats are refed a high carbohydrate diet, enzyme activity may increase up to ten times the
fasted level in 72 hours. Extensive research has been done to explain this phenomenon
for G6PD, and the general conclusion is that the overshoot is caused by increased
protein synthesis. However, the possibility that there is activation of the enzyme has
not been ruled out. Recent work has shown that other lipogenic enzymes are glycoproteins and may have GPI anchors that contribute to their regulation by shifting the enzymes from particulate to soluble fractions. G6PD was analyzed to see if it too shared these characteristics.
The sensitive digoxigenin-labeling method was used to confirm that G6PD is a glycoprotein. SDS-PAGE analysis showed matching migration patterns for protein, activity, antibody reactivity, and carbohydrate staining for both yeast and rat liver
G6PD. Treatment of yeast mitochondria with phosphatidyl inositol specific phospholipase c resulted in increased enzyme in the supernatant indicating that G6PD was bound to the mitochondria via a GPI anchor. Additionally, digitonin fractionation of rat liver mitochondria showed that G6PD is associated with the outer mitochondrial membrane. ii Male, Sprague Dawley rats were fed a high carbohydrate diet or fasted for 48
hours and refed a high carbohydrate diet and G6PD activity and quantity measured in
the cytosol and mitochondria to determine the subcellular distribution of the enzyme.
G6PD activity in the mitochondrial-free supernatant was 2.5 to 3.5 times greater in
refed rats compared to fed rats. In the mitochondria, the activity was up to twice as
high in refed rats. There was no difference in G6PD quantity between fed and refed rats
in either cellular compartment. Mitochondria had ten times as much enzyme as the mitochondrial-free supernatant, but the activity was only one tenth as much.
When expressed as actual enzyme specific activity (mU/amount enzyme), the mitochondrial-free supernatant G6PD was seven times higher in refed rats compared to fed rats. The refed rats had twice as much mitochondrial specific activity. Results showed that mitochondrial G6PD is very low in activity while the mitochondrial-free supernatant became much more active when fasted rats were refed a high carbohydrate diet. These results indicated that the overshoot in G6PD activity was due to increased activation of the enzyme which may be unrelated to the presence of carbohydrate attached to the protein or shifts in subcellular location.
Kinetic studies were performed with G6PD in fed and refed rats to explain better the increased activation of the enzyme. The Vmax for fed rats was 0.041mU/mg protein versus 0.096mU/mg protein for refed rats. These results were expected, however an unexpected difference in Km values was found. Fed rats had a Km of
28.8uM while refed rats had a Km of 55.9uM. These results show that there may be a different form of the enzyme present in refed rats that has distinct characteristics.
Ill Dedicated to my husband, John, and to the little one who provided a deadline for me to complete this project.
IV ACKNOWLEDGMENTS
There are many people to acknowledge who contributed to my graduate
experience. Foremost is my advisor. Dr. John Allred, who is a wonderful mentor and
has become a good friend. I realize that the advisor-student relationship is typically not
perfect, but I think in this case there was a good mesh of personalities which resulted in
a friendly, companionable work environment. Dr. Allred is a great role model for an
educator and researcher and some day I hope to be half as successful with my students as he is with his. I thank him for his guidance and patience, and seemingly photographic memory, but most of all his companionship.
I would like to thank Drs. Roehrig and McCune for taking the time to be on my committee and for their manuscript suggestions. I also appreciate having them as educators who fostered creative thinking and problem solving. And I thank them for their willingness to lend an ear or provide a piece of advice when the situation warranted. I thank Richard Jurin for the same ability.
Thank you to all my fellow students who became fnends and made my time at
Ohio State enjoyable—Jason Chou, Luther Chuang, Dave Smith, Heidi Senokozliefif,
Isabel Schuermeyer, and Kristin Pape. I truly don't think I could have survived without you. I'm grateful for the brainstorming sessions, one-on-one advice, and most of all the camaraderie. There's more to life than research and studies and we discovered that together. The best times were the times I could wander down the hail and find a
fiiendly ear to provide a little break for a while. Thank you all for that.
Finally, I would like to thank my husband, John. Your support over the past
four and a half years has been astounding. From the first stress-filled quarters when
going back to school was a foreign concept to the past few months when the final crush was on, you were always there to boost my spirits and pick up the slack. I know you say you're proud of me for what I've accomplished, but I'm just as proud of you for going through this with me.
VI VITA
November 22, 1968...... Bom - Akron, OH
1991...... B.S. Chemistry, John Carroll University
1991 - 1993...... Research Scientist New Projects Department The Lubrizol Corporation WicklifFe, OH
1993 - 1994...... Graduate Research Assistant The Ohio State University
1994 - Present...... USDA National Needs Fellow The Ohio State University
PUBLICATIONS
Research Publications
1. Reilly KE, Allred JB. (1995) Glucose-6-Phosphate Dehydrogenase from Saccharomyces cerevisae is a glycoprotein. Biochem. and Biophys. Res. Com. 216(3):993-8.
2. Allred JB, Reilly KE. Short-term regulation of acetyl CoA carboxylase in tissues of higher animals. (1996) Progress in Lipid Research, Elsevier Press, Oxford 35(4):371-85.
FIELDS OF STUDY
Major Field; Food Science and Nutrition
Vll TABLE OF CONTENTS
Abstract...... ii
Dedication ...... iv
Acknowledgments ...... v
Vita...... vii
List of Tables...... x
List of Figures...... xi
List of Abbreviations ...... xiii
Chapters:
Introduction ...... 1
1. Literature Review ...... 4 GIucose-6-Phosphate Dehydrogenase ...... 4 Lipogenic Enzymes ...... 5 Glycoproteins and GPI Anchors ...... 7 Digitonin Fractionation ...... 14 Particulate Forms of Lipogenic Enzymes ...... 16 Overshoot in G6PD Activity ...... 21
2. Methods and Materials ...... i5 Baker’s Yeast Studies ...... 35 Separation of Cytosol and Mitochondria ...... 35 Separation of Yeast Outer Mitochondrial Membrane and Treatment with PI-PLC ...... 36 Protein Determination ...... 37 Preparation of SDS-Boiled Samples ...... 37 Polyacrylamide Gel Electrophoresis ...... 38 Denaturing Gel ...... 38 Non-Denaturing G el ...... 38 viii Western Blot ...... 40 Antibody Detection of G6PD ...... 40 Quantitative Determination of G6PD ...... 41 G6PD Activity Stain of Non-Denaturing Gel ...... 43 Glycan Chain Detection of G6PD ...... 46 Enzyme Assays ...... 47 Animal Studies ...... 48 Animal Care ...... 48 Isolation of Livers ...... 50 Separation of Cytosol and Mitochondria ...... 50 Separation of Liver Mitochondrial Fractions (Digitonin Fractionation) ...... 51 Separation of Outer Mitochondrial Membrane in the Rat Liver... 52 Glycogen Determination ...... 54 Enzyme Kinetic Study of Rat Liver G6PD ...... 54 Materials...... 55 Statistics...... 55
3. Results and Discussion ...... 56 Yeast Studies ...... 56 Stability of Yeast G6PD ...... 59 Glycoprotein Analysis of Purified Yeast G6PD ...... 59 Treatment of Yeast Mitochondria with PI-PLC ...... 66 Animal Studies ...... 68 48-Hour Refeeding Study ...... 70 Short Term Refeeding Study ...... 79 Long Term Refeeding Study ...... 79 Enzyme Kinetic Studies for Rat Liver G6PD ...... 92 Electrophoretic Mobility Study for Rat Liver G6PD ...... 95
4. Conclusions ...... 100
References ...... 102
IX LIST OF TABLES
Table Page
2.1 Composition of Denaturing Polyacrylamide Gels ...... 39
2.2 Composition of Non-Denaturing Polyacrylamide Gels ...... 39
2.3 Composition of Diet ...... 49
2.4 Protease Inhibitors ...... 53
3.1 Specific Activity of G6PD in Yeast ...... 57
3.2 Quantity of G6PD in Yeast ...... 57
3.3 G6PD Specific Activity and Quantity in Rat Liver Mitochondrial-Free Supernatant ...... 71
3.4 G6PD Specific Activity and Quantity in Rat Liver Mitochondria ...... 73
3.5 G6PD Activity Per Quantity (mU G6PD/ug G6PD) in Rat Liver...... 75
3.6 Short Term Refeeding Study ...... 80
3.7 G6PD Quantity in Fed and Refed Rats ...... 86 LIST OF FIGURES
Figure Page
1.1 Structure of a Typical GPI-Anchored Protein ...... 12
2.1 Densitometer Readout from Rat Liver Quantitative Analysis ...... 42
2.2 Standard Curve for Yeast Studies ...... 44
2.3 Standard Curve for Rat Liver Studies ...... 45
3.1 Activity and Quantity of Yeast G6PD ...... 58
3.2 Stability of Yeast G6PD ...... 60
3.3 Molecular Weight Determination of Yeast G6PD ...... 62
3.4 Glycoprotein Detection of Yeast G6PD ...... 63
3.5 Glycoprotein Detection of Rat Liver G6PD ...... 65
3.6 Yeast G6PD Released by Phosphatidyl Inositol Specific Phospholipase C...... 67
3.7 Rat Liver Digitonin Fractionation ...... 69
3.8 G6PD Activity and Quantity in Rat Liver Mitochondrial-Free Super-^8-Hour Study ...... 72
3.9 G6PD Activity and Quantity in Rat Liver Mitochondria— 48-Hour Study ...... 74
3.10 G6PD Activity Analysis in Mitochondrial-Free Super— 48-Hour Study ...... 77
XI 3.11 G6PD Activity Analysis in Mitochondria—48-Hour Study ...... 78
3.12 G6PD Activity in the Mitochondrial-Free Supernatant— 36-Hour Study ...... 81
3.13 G6PD Activity in Mitochondria—3 6-Hour Study ...... 82
3.14 G6PD Activity in Fed Rats—36-Hour Study ...... 84
3.15 G6PD Activity in Refed Rats—36-Hour Study ...... 85
3.16 G6PD Activity Per Amount in Mitochondrial-Free Super— 36-Hour Study ...... 88
3.17 G6PD Activity Per Amount in the Mitochondria—3 6-Hour Study ...... 89
3.18 6PGD Activity in Mitochondrial-Free Supernatant— 36-Hour Study ...... 90
3.19 Glycogen Content in Rat Liver—3 6-Hour Study ...... 91
3.20 Rat Liver G6PD Kinetic Study—Velocity Plot ...... 93
3.21 Rat Liver G6PD Kinetic Study—Lineweaver-Burke Plot ...... 94
3.22 Densitometry Scan of G6PD Activity; Electrophoretic Mobility A—Fed Rats, B—Refed Rats ...... 97
3.23 Densitometry Scan of G6PD Antibody Reactivity: Electrophoretic Mobility A—Fed Rats, B—Refed R ats ...... 98
Xll LIST OF ABBREVIATIONS
ACC...... Acetyl CoA carboxylase Act...... Activity AdKi ...... Adenylate kinase ADP...... Adenosine diphosphate AMP...... Adenosine monophosphate ESA...... Bovine serum albumin OC ...... Degree Celsius Carbo...... Carbohydrate cAMP...... Cyclic adenosine monophosphate cDNA...... Complimentary deoxyribonucleic acid CoA...... Coenzyme A CytC ...... Cytochrome c oxidase Cyto...... Mitochondrial-free supernatant ECL...... Enhanced chemiluminescence reagent EDTA...... Ethylene diamine tetraacetic acid GC...... Gas chromatography G6P...... Glucose-6-phosphate G6PD...... Glucose-6-phosphate dehydrogenase GPI...... Glycosyl phosphatidyl inositol GSSG...... Oxidized glutathione GW ...... Greenawalt's H r...... Hour K ...... Thousand Kda ...... Kilodalton kg...... Kilogram L ...... Liter LPL...... Lipoprtoein lipase M ...... Molar MAO...... Monoamine oxidase MS...... Mass spectroscopy Max...... Maximum MDH...... Malate dehydrogenase Min ...... Minute Mito...... Mitochondria mg...... Milligrams xiii ml...... Milliliters mRNA...... Messenger ribonucleic acid mU...... Milliunits NAD...... Nicotinamide adenine dinucleotide NADP ...... Nicotinamide adenine dinucleotide phosphate NADPH...... Nicotinamide adenine dinucleotide phosphate (reduced form) ng...... nanograms nm ...... nanometers O.D...... Optical density PAGE...... Polyacrylamide gel electrophoresis PBS...... Phosphate-buffered saline PI-PLC...... Phosphatidyl inositol-specific phospholipase c PMSF...... Phenylmethyl sulfonylfluoride Prot...... Protein 6PGD...... 6-Phosphogluconate dehydrogenase Quant ...... Quantity S ...... Substrate SDS...... Sodium dodecyl sulfate SEM...... Standard error of the mean Soln ...... Solution Sp act...... Specific activity Super ...... Supernatant mM...... Millimolar TEMED...... N,N,N",N"-Tetramethylethylenediamine TBS...... Tris-buffered saline U...... Unit ug...... Micrograms uM ...... Micromolar V...... Velocity Vmax...... Maximum velocity VSG...... Variant surface glycoprotein w/v...... Weight/V olume
XIV INTRODUCTION
Glucose-6-phosphate dehydrogenase (G6PD) [E.G. 1.1.1.49] is the key regulatory enzyme for the pentose phosphate pathway. This enzyme catalyzes the reaction of glucose-6-phosphate to 6-phosphoglucono lactone which also produces reducing equivalents (NADPH) for a variety of biosynthetic processes, including fatty acid synthesis. For this reason it belongs to a class of enzymes known as lipogenic enzymes whose activities are known to increase under conditions of de novo lipid biosynthesis.
Animal studies have shown that refeeding a high carbohydrate diet to an animal that has previously been fasted results in increased lipogenesis and an overshoot in
G6PD activity compared to animals that have been fed a normal rat chow diet (1,2).
Many studies have been undertaken to determine why this great increase in activity occurs. Two main regulatory mechanisms that have been explored are increased protein synthesis and increased activation of the enzyme. Arguments for increased synthesis of
G6PD (3, 4, 5) have been strong, but the area of increased activation of the enzyme has not been fully explored (6, 7, 8). G6PD normally functions in the cytosol (9, 10), but particulate forms have also
been found in rat liver peroxisomes (11,12) and mitochondria (13, 14), and rabbit liver
microsomes (15). Particulate forms of other lipogenic enzymes have also been
characterized. ATP citrate lyase [E.C. 4.1.3.8] has been found in rat liver mitochondria
(16-18) and had more enzyme associated with the particulate fraction in fasted rats than
in fed rats (18). Acetyl CoA carboxylase [E.C. 6.4.1.2] has also been found in rat liver
mitochondria (19- 23) and showed a shift to soluble form upon fasting and refeeding
(20). It appears that these two lipogenic enzymes are ambiquitous in that they change
their cellular location based upon the physiological conditions of the cell.
Acetyl CoA carboxylase was proven to be a glycoprotein, and evidence
indicated that the enzyme was attached to a membrane via a glycosyl
phosphatidylinositol anchor (24). The enzyme was localized to the outer mitochondrial
membrane in this subcellular fraction (21). This particular linkage and association
would allow the enzyme to be cleaved from the membrane under lipogenic conditions
and could be a valuable means of regulation.
G6PD has many of the same characteristics as the other lipogenic enzymes,
specifically changes in enzyme activity concurrent with dietary changes. Since
particulate forms of some lipogenic enzymes have shown shifts in location upon
refeeding a high carbohydrate diet (18, 20), G6PD should also be analyzed to see
whether it exhibits this property. Additionally, acetyl CoA carboxylase is an inositol- containing glycoprotein and is attached to the outer mitochondrial membrane, and
G6PD should be investigated to determine if it shares these same characteristics. Specific Alms
The purpose of this research is to characterize G6PD as a glycoprotein,
determine if it has a glycosyl phosphatidylinositol anchor, and address the possibility
that the particulate form has a role in regulation of the enzyme under differing dietary
conditions. To accomplish these goals, yeast G6PD from Saccharomyces cerevisiae
was used in preliminary experiments due to its ready availability and unicellular
characteristics. The possible presence of carbohydrate was explored using the sensitive
digoxigenin labeling method and phosphatidyl inositol specific phospholipase c used to
examine the presence of a glycosyl phosphatidylinositol anchor. Male Sprague Dawley
rats were used to determine the distribution of liver G6PD between the cytosol and
mitochondria in fed, fasted, and fasted/ high carbohydrate refed animals. Both activity
and quantity of the enzyme were measured to assess possible shifts in subcellular
location of the enzyme. This research will add to the already great body o f knowledge concerning the regulation of G6PD by investigating the little-explored area of subcellular distribution of the enzyme. CHAPTER 1
LITERATURE REVIEW
Glucose-6-Phosphate Dehydrogenase
Glucose-6-phosphate dehydrogenase (G6PD) is a metabolic enzyme that is
widely distributed in nature and has been found in all organisms and cell types (9,25).
Its nucleotide sequence has been greatly conserved from Drosophila to humans (26, 27).
As the first enzyme in the pentose phosphate pathway, G6PD functions at a branch
point in metabolism in that it produces glycolytic intermediates, 5-carbon rings for
nucleotide synthesis, and NADPH for a number of reactions including fatty acid
biosynthesis. Thus, G6PD is involved in both carbohydrate and lipid metabolism.
Because of its presence in most cells and its pivotal role in metabolism, its
characteristics and regulation have been extensively studied.
G6PD is known to have three different active forms when analyzed by non
denaturing polyacrylamide gel electrophoresis (4, 10, 28-31). These three forms are thought to be multiple subunits arranged in dimers, tetramers, and hexamers since the molecular weights are in a ratio of 1:2:3 (28). The inactive subumit has a reported molecular weight of 56-67,000 in yeast (27, 32) and several mammalian tissues (10, 28,
29, 33-35) while the main active forms are 121-130 lcDa(10,29, 34). Although multiple forms of G6PD exist, Watanabe and co-workers (36) found no difference in kinetic or
immunological properties among the different forms.
The reaction catalyzed by G6PD occurs primarily in the soluble fraction of the
cell (9, 10). It requires glucose-6-phosphate (G6P) almost exclusively as a substrate,
and the enzyme from most sources requires NADP to produce the reducing equivalents
(NADPH) for processes such as fat and cholesterol biosynthesis. Magnesium is also
required as an activator of the enzyme for most species. The products of the G6PD
reaction are 6-phosphoglucano lactone which is non-enzymatically converted to 6- phosphogluconate and NADPH. The oxidative phase of the pentose phosphate pathway concludes with the formation of ribulose-5-phosphate through the action of 6- phosphogluconate dehydrogenase (6PGD) via oxidative decarboxylation. NADPH is also produced at this step making these two reactions the major source of reducing equivalents in a cell (37).
Lipogenic Enzymes
G6PD is just one of a class of enzymes known as lipogenic enzymes. This group is responsible for fatty acid biosynthesis in organisms and includes ATP-citrate lyase, acetyl CoA carboxylase, fatty acid synthase, and malic enzyme. ATP-citrate lyase cleaves cytosolic citrate to form oxaloacetate and acetyl CoA. Acetyl CoA carboxylase adds a carboxyl group to acetyl CoA to form malonyl CoA as the first step in fatty acid biosynthesis while fatty acid synthase is necessary for fatty acid formation.
Malic enzyme also produces NADPH. These five enzymes share similar regulatory mechanisms in that the levels of all of them rise or fall together in response to nutritional changes (I). The enzyme activities of the lipogenic enzymes decrease with starvation and low levels of insulin and increase with carbohydrate refeeding (I). In isolated rat hepatocytes, glucose and insulin added to the media caused an increase in lipogenic enzyme mRNA concentration while fatty acids decreased the mRNA concentration (38). Increasing the amount of diet upon refeeding carbohydrate to previously starved rats caused an increase in lipogenic enzyme activity, transcriptional rate, and mRNA concentration (39).
Although not involved in fatty acid synthesis per se, there are other lipogenic enzymes involved in lipid metabolism that have similar activity patterns to the lipogenic enzymes. Their activities increase under lipogenic conditions. 3-Hydroxy-3- methylglutaryl-CoA reductase (HMG CoA reductase) is the rate-limiting enzyme in cholesterol biosynthesis. Lipoprotein lipase hydrolyzes fatty acids from circulating lipoproteins and deposits them in adipose cells. Research has shown that these two enzymes contain carbohydrate and can be classified as glycoproteins (40-43).
Particulate forms of other lipogenic enzymes have been found (16-23) and acetyl CoA carboxylase was shown to be a glycoprotein and possibly possesses a glycosyl phosphatidyl inositol anchor (24). Glycoproteins and GPI Anchors
Glycoproteins
A glycoprotein is a protein with a glycan chain (or oligosaccharide) covalently
attached. Increasing evidence has shown that most mammalian proteins contain sugar
chains (44). Glycoproteins have diverse functions such as maintenance of protein
conformation and solubility, proteolytic processing and stabilization of the polypeptide
against uncontrolled proteolysis, mediation of biological activity, intracellular sorting
and extemalization of glycoproteins, and embryonic development and differentiation
(45). The carbohydrate chains may contain any of seven sugars—galactose, glucose,
mannose, fucose, N-acetylneuraminic acid, N-acetylgalactosamine, and N-
acetylglucosamine. Sialic acid is usually present as well at chain termini (37). Glucose
is rarely found in a glycan chain. Typically a glycan chain has fifteen sugars with 1-30
glycan chains per glycoprotein. Therefore, the carbohydrate can be anywhere from I to
85% of the molecular weight of the glycoprotein (37). The different types of sugar residues and the almost unlimited number of linkages possible for a glycan chain allow for extensive branching and great diversity in glycoproteins.
Structurally glycoproteins can be classified into two groups. N-linked glycoproteins have an N-acetylglucosamine linked to an asparagine residue of the protein. The common sequence pattern is ASN-X-SER(THR) where X is any amino acid but proline or aspartate. 0-linked glycoproteins have an N-acetylglucosamine linked to a serine or threonine. This sequence pattern necessary for attachment is ASN-
Y-SER(THR) where Y is any amino acid but aspartate (37). Additionally, glycoproteins can be classified according to their sugar types (44). High mannose
chains contain only mannose and N-acetyl glucosamine residues. Complex chains
contain mixed sugars such as galactose, mannose, fucose, N-acetyl glucosamine, and
sialic acid but no mannose except in the anchoring core. Hybrid types are a mixture of
high mannose and complex types.
Many methods have been developed to help identify and characterize
glycoproteins. Gas chromatography/mass spectroscopy (GC/MS) can be used to detect
the presence of sugars. Lectins are available which are proteins from plants, which bind
sugars. Lectins can be immobilized on a column support and the potential glycoprotein
added to see if it becomes bound (37). Concanavalin A is a popular lectin that binds
sugars. It detects carbohydrate and can distinguish among the types of glycan chains
(44). Complex-type glycans which have two binding residues become bound to the Con
A column and are eluted with 5mM methyl a-glucopyranoside. High mannose-type
glycans become bound and are eluted only with 200mM methyl a-mannopyranoside.
Glycan chains with only one binding residue pass through the column.
Endoglycosidases such as endo F and endo H cleave certain N-acetylglucosamine
residues close to the polypeptide and are a useful tool in analyzing glycoproteins (44).
A suspected glycoprotein can be treated with an endoglycosidase and analyzed by gel
electrophoresis to determine whether a shift in molecular weight occurred indicating
loss of a glycan chain. If the glycan chain is too small to have an effect on molecular weight shifts, the glycan can be labeled and the absence of label after treatment
indicates the loss of carbohydrate. One popular method to label glycoproteins is with
8 tritiated borohydride (46). The protein is treated with galactose oxidase, which oxidizes
non-reducing terminal galactosyl and N-acetylgalactosamine residues to their
corresponding C-6 aldehydes. Next, the aldehydes are reduced back to their original
sugars with the addition of tritiated borohydride, which labels the sugar with a ^H.
Biochemical methods are then employed to detect the radiolabel.
A relatively new method for detecting carbohydrate attached to protein is simple
and involves no radioactivity. Adjacent hydroxyl groups on sugar residues can be
oxidized to aldehyde groups with periodate treatment. The potential glycoprotein is
then treated with the hapten digoxigenin, which becomes covalently attached to the
aldehyde by a hydrazide group (47). The digoxigenin-labeled glycoconjugate can then be detected using an anti-digoxigenin antibody conjugated with alkaline phosphatase or
horseradish peroxidase. Digoxigenin labeling can be performed on proteins in solution or immobilized on nitrocellulose. The antibody attachment is done after the protein has been immobilized on nitrocellulose. This method is highly specific and extremely sensitive for carbohydrate (47).
Glvcosvl Phosphatidvlinositol Anchors
Glycosyl phosphatidylinositol (GPI) anchors are a relatively newly discovered mechanism to attach proteins to membranes. Rather than having a hydrophobic region on the protein interact with the lipid bilayer of the membrane, the protein is bound with a phosphatidyl inositol linker attached to a glycan moiety of the protein (48). Proteins that utilize this kind of attachment are widely distributed between different organisms from yeast and mold to Drosophila and mammalian tissues (49). Although over 100
GPI-anchored proteins have been discovered, there is no evidence of their existence in prokaryotes or plants (50). Alkaline phosphatase was one of the first proteins shown to have a GPI anchor (51). It was shown to be released from mammalian tissue by treatment with phosphatidylinositol-specific phospholipase c (PI-PLC). This enzyme is believed to hydrolyze specifically phosphatidylinositol and phosphatidylinositol mannosides (48). Examples of other proteins characterized as having GPI anchors are placental alkaline phosphatase, decay accelerating factor, acetylcholinesterase,
5'nucleotidase, Thy-1 glycoprotein, and the variant surface glycoprotein (VSG) from
Trypanosoma bnicci (48, 52). Most of the GPI-anchored proteins that have been studied are anchored on the cellular surface, but this may be because it is easier to study that membrane than intracellular structures (51). Since this body of these proteins is so diverse, a protein would have to be specifically targeted and extensively studied to see if it also contains a GPI structure.
It was found that treatment of GPI-anchored proteins with PI-PLC released soluble, intact proteins and left the membrane moiety intact (48, 51). The molecular weight of released proteins was similar to that of native proteins. Since PI-PLC specifically cleaves between the phosphate and 1,2 diacylglycerol of phospholipids, it was likely that 1,2 diacylglycerol served as the membrane anchor (48). Some proteins believed to be GPI-anchored proteins may be resistant to release by PI-PLC (51). This is because PI-PLC from different sources may not have the same specificity for all proteins, and the individual proteins are not equally reactive to PI-PLC. Additionally,
10 some GPI-anchored proteins have a third fatty acid that attaches the inositol to the
membrane and these proteins are insensitive to PI-PLC treatment (52, 53). Recent work
using protein engineering of cell surfaces has shown that a clipped GPI-anchored
protein can be reattached to a membrane (53). This has introduced techniques for
genetically adding a GPI anchor to a non-GPI-linked protein and directing them to a
membrane.
A^o-inositol is not a normal constituent of proteins and its presence can easily
be confirmed by GC/MS analysis to indicate the possible presence of a GPI-anchored
protein (51). The diverse GPI-anchored proteins have other characteristics in common
as well. They all contain ethanolamine (1:1 molar ratio for VSG, 2:1 for Thy-1 and acetylcholinesterase), glucosamine (1 mol:l mol), and glycerol, phosphate, and fatty acid where analyzed (51). Other carbohydrates are also present although the same ones are not present in all GPI-anchored proteins. VSG contains mannose and galactose and
Thy-1 contains mannose and galactosamine (51). The fatty acid portion of the protein complex also differs. VSG contains only myristate while acetylcholinesterase contains a mixture including palmitate and Thy-1 contains stearate and two longer chain fatty acids (50, 51). The schematic for a typical GPI-anchored protein is shown in Figure
I.l. The 1,2 diacylglycerol is embedded in the membrane and the phosphatidyl inositol attached to it. The inositol is attached to a glycan chain of varied structure via a glycosidic linkage with glucosamine. The glycan is attached to an ethanolamine residue that is linked to the C-terminal end of the protein.
11 QLYCAN
tm
* Adapted from Reference 52.
Figure 1.1 Structure of a typical GPI-Anchored Protein*
As indicated in Figure 1.1, the anchoring domain of the GPI-anchored protein is attached at the C-terminal end. Studies with VSG showed that the cDNA sequence contained 17-23 amino acid residues at the C-terminus that were missing in the mature protein while Thy-1 had 31 residues removed during processing (51). They were probably removed and replaced with the glycan structure during processing. GPI- anchored proteins contain a similar hydrophobic N-terminus, which directs them to the endoplasmic reticulum for processing (49, 51). The C-terminal residues that are removed also have a hydrophobic region that includes several charged or hydrophilic residues (49, 51, 53). Otherwise there is no common amino acid sequence among the GPI proteins. The addition of the glycan moiety is rapid (within I minute for VSG)
which implies that the glycolipid structure is preconstructed before addition (49, 53).
Lipoeenic Enzymes Characterized as Glycoproteins
As mentioned previously, HMG-CoA reductase has been characterized as a glycoprotein. UT-1 cells are hamster cells, which have been genetically altered to express -500 times the normal amount of HMG CoA reductase and have been used to analyze this enzyme. Work by Liscum et a l(40) with UT-1 cells showed that HMG
CoA reductase is a transmembrane N-linked glycoprotein of the high mannose type.
The researchers showed that HMG CoA reductase bound to Con-A sepharose and exhibited a decrease in molecular weight when treated with endo H. Additionally, the enzyme incorporated [1,6^H]glucosamine into its structure. Volpe and Goldberg (41) using C -6 glial cells found that tunicamycin administration decreased HMG CoA reductase activity and cholesterol synthesis. Tunicamycin is an inhibitor of glycoprotein synthesis. The authors concluded that HMG CoA reductase is a glycoprotein, and the synthesis of the glycoprotein is necessary for activity.
Lipoprotein lipase (LPL) has not only been proven to be a glycoprotein (42), it has been shown to be attached to the cellular membrane by a GPI anchor (43). 3T3-L1 cells, which differentiate to adipocytes, are commonly used to investigate lipoprotein lipase. In the late 1970's Spooner et al (54) found that LPL activity was proportional to insulin levels. Insulin (10*^-10'^°M) increased LPL release from 3T3-L1 cells rapidly and increased its activity slowly. The authors concluded that the rapid release was
13 independent of energy metabolism and protein synthesis. In the late 1980's insulin was
linked to PI-PLC activity (43, 55). Saltiel and Cuatrecasas (55) used BC 3HI cells (from
a murine myocyte cell line) to show that insulin stimulated the activity of PI-PLC and
released a carbohydrate-containing substance from the cell membrane. Chan et al (43)
concluded that insulin was the predominant regulator of LPL in 3T3-L1 cells and the rapid release caused by insulin was due to the action of PI-PLC. The kinetics of release induced by insulin were the same as those of PI-PLC. Since HMG-CoA reductase and lipoprotein lipase are both glycoproteins and lipoprotein lipase has a GPI anchor, other lipogenic enzymes may have similar properties.
Digitonin Fractionation
In order to understand fully metabolic regulation, the location of all metabolites and enzymes must be fully established. A widely used technique to help elucidate the subcellular distribution of enzymes and pinpoint the location of particulate forms of enzymes is known as digitonin fractionation. Digitonin complexes with cholesterol and has been used for years to extract cholesterol in biological samples. In the fractionation procedure, digitonin is used to disrupt cellular membranes, which contain large amounts of cholesterol (28). If whole cells are used, the cholesterol content of the various membranes can be used to preferentially separate cell components by incubating with digitonin for various amounts of time (18). Plasma membrane cholesterol content is greater than outer mitochondrial and endoplasmic reticulum content, which is greater than inner mitochondrial membrane cholesterol content. This procedure has been used
14 to determine the distribution of some enzymes between the cytosol and mitochondria in
rat hepatocytes by comparing the rate of release of a given enzyme with that of known
marker enzymes (17).
If it has been established that an enzyme is mitochondrial, it is desirable to
determine where it is located in the mitochondria. The digitonin fractionation
procedure can be used on isolated mitochondria to disrupt the outer and inner
membranes (28, 56). Mitochondria are isolated by centrifugation and incubated with
digitonin at 0°C at a specified ratio of digitonin to protein. Although its exact
contribution is unknown (56), bovine serum albumin must be added to the reaction mix for complete results, perhaps to stabilize dilute enzyme protein. The resultant fractions are then centrifuged. The ratio of digitonin to mitochondria can be manipulated to obtain clean fractions of outer or inner mitochondrial membrane (56) or various concentrations used and the enzymes measured in the supernatant of the subsequent centrifugal spin to determine their release pattern (21). Some researchers have kept the digitonin concentration constant and varied the time of incubation to disrupt preferentially the mitochondrial membranes (16, 18).
A number of enzymes have been linked to specific fractions of the mitochondria and can be used as markers. For example, monoamine oxidase is a known outer mitochondrial enzyme and is released at low digitonin concentrations (28). Adenylate kinase is located between the inner and outer mitochondrial membranes and has a release pattern which starts at a lower digitonin concentration than monoamine oxidase
(28). This occurs because the enzyme is quick to 'leak' from its compartment once a
15 portion of the outer mitochondrial membrane has been disrupted. Cytochrome c
oxidase can be used as a marker for the mitochondrial matrix, and malate
dehydrogenase for the soluble matrix (21). Higher concentrations of digitonin or longer
incubation times are needed to release the latter two enzymes. The activities of the
enzyme in question and all marker enzymes are measured in each fraction and the
patterns of release compared to determine the location of the unknown enzyme (21).
This procedure has been used to localize ATP citrate lyase in the mitochondria (16-18)
and acetyl CoA carboxylase to the outer mitochondrial membrane (21).
Particulate Forms of Lipogenic Enzymes
O f the lipogenic enzymes, G6PD, ATP citrate lyase, and acetyl CoA
carboxylase are known to have particulate forms.
ATP Citrate Lvase
Janski and Cornell (19-18) have used the digitonin fractionation procedure to discover that ATP citrate lyase is found in the mitochondrial preparation of rat liver cells. Upon further investigation, when rats were fasted, 52% of the enzyme's activity was associated with the mitochondria compared to 21% for fed rats and 24% for fasted- refed rats (18). Thus, the change in the physiological state of the animal between fasted and fed or refed states caused ATP citrate lyase content to decrease in the mitochondria and increase in the cytosol. Presumably the enzyme was released from its particulate form. The addition of 20uM CoA to the digitonin fractionation medium also caused a
16 reduction in mitochondrial ATP citrate lyase while a reduction in cellular CoA
increased the particulate amount (18). Also, citrate and ATP added to the medium
caused the ATP-citrate lyase shift to the cytosol (16). The localization of the enzyme
with the mitochondrial membrane might allow it to easily bind citrate and efficiently
form acetyl CoA during times when the cell is not involved with fat synthesis. Citrate
could change the pH of the cell or the free magnesium concentration if it were to
accumulate. Due to these changes in ATP citrate lyase's location under differing
metabolic conditions it has been characterized as an ambiquitous enzyme.
Acetvl CoA Carboxvlase
Witters et a/ (19) were the first to report in recent years of an association of
acetyl CoA carboxylase with microsomes using ^^P labeled enzyme and
immunoprécipitation of rat liver hepatocytes. This was followed by work done by
Allred and co-workers (20-23) who discovered a mitochondrial form of acetyl CoA
carboxylase that was relatively inactive. The enzyme could be quantitated by
incubating SDS-denatured protein with [*'*C]methyl avidin, which binds to the biotin
moiety of acetyl CoA carboxylase, and subjected to polyacrylamide gel electrophoresis
(23). After exposure to X-ray film and fluorography, the protein could be quantitated by densitometry. Results showed that 50% of the acetyl CoA carboxylase in rat liver was associated with the mitochondria in fed rats, and fasting-refeeding shifted the amount toward the cytosol (20). In alloxan diabetic rats, the activity of acetyl CoA carboxylase is decreased along with the rate of lipogenesis. A theory for this
17 occurrence is that insulin needs to be present to synthesize the enzyme. Measurement
of acetyl CoA carboxylase in acutely diabetic rats, however, showed that there was less
enzyme in the cytosol but a greater amount in the mitochondria, which was mostly
inactive (22). It was proposed that insulin, in addition to a putative role in enzyme
synthesis, is also involved in the mobilization and activation of acetyl CoA carboxylase
from an inactive mitochondrial to an active cytosolic form.
Further studies of the quantitation of this enzyme revealed two antibody reactive
mitochondrial forms which, when added together, accounted for 75% of the total acetyl
CoA carboxylase quantity in the cell (21). 3.5% of the enzyme was microsomal and the remainder cytosolic. The specific activity of cytosolic acetyl CoA carboxylase was 16.4 mU/mg protein versus 1.8mU/mg protein for the mitochondrial form. Quantitatively, the cytosol had 3.1 nmol/g liver of the enzyme while the mitochondria had 5.7 and 4.3 nmol/g liver for the two forms. The actual specific activity of the enzyme could also be calculated. The cytosolic enzyme at 2.0 units/mg acetyl CoA carboxylase was 20 times more active than the mitochondrial enzyme at 0.09 units/mg acetyl CoA carboxylase showing that most of the acetyl CoA carboxylase was in an inactive mitochondrial form.
Digitonin fractionation was used to determine the location of the acetyl CoA carboxylase in the mitochondrial fraction (21). Both forms of mitochondrial acetyl
CoA carboxylase showed the same release pattern as monoamine oxidase indicating an association with the outer mitochondrial membrane. This location would allow the enzyme to be easily accessible for release or activation under lipogenic conditions.
18 Since acetyl CoA carboxylase was found to be associated with the outer
mitochondrial membrane, experiments were performed to determine whether it
contained a carbohydrate moiety, which could be used as an anchoring mechanism.
Bowers (24) determined that acetyl CoA carboxylase was a glycoprotein based on
several lines of evidence. GC/MS analysis confirmed the presence of mannose,
galactose, flicose, N-acetylglucosamine, and inositol in acetyl CoA carboxylase purified
from rat liver. The enzyme bound to a Con A sepharose column and was eluted by
methyl a-mannopyranoside. Additionally, gel electrophoresis followed by treatment
with the digoxigenin/anti-digoxigenin detection system showed a positive stain for
carbohydrate at the same mobility as the anti-acetyl CoA carboxylase antibody stain.
The presence of inositol associated with the purified enzyme introduced the possibility that acetyl CoA carboxylase has a GPI anchor.
Glucose-6-Phosphate Dehvdroeenase
Although G6PD is known to be a cytosolic enzyme and perform primarily in that part of the cell, particulate forms of the enzyme have been found. As early as 1965
Zaheer (13, 14, 57) discovered the presence of G6PD in rat liver mitochondria.
Extensive studies were performed on fresh and frozen liver in male and female rats.
Mitochondrial fractions were separated by centrifugation and the enzyme activity measured. It was discovered that the addition of Triton X-100 detergent to the reaction media helped maximize G6PD activity in mitochondrial fractions (57). Additionally, optimal G6PD activity was elicited by using a freeze-thaw cycle of rat liver
19 mitochondria (13). Since a combination of treatments was necessary to achieve full
activity, it was thought that G6PD must be firmly bound to the mitochondria. The
G6PD activity of the mitochondrial fraction was 20% that of the cytosolic fraction in
female rats and 40% in male rats. The female rats did not show a difference in G6PD
activity in the mitochondria compared to males although cytosolic G6PD activity was
higher in female rats. 6-PhosphogIuconate dehydrogenase was also found in the
mitochondria at 15% of the total cellular activity (13). Zaheer also purified G6PD from
both cytosol and mitochondria (13). Mitochondrial G6PD was found to be distinctly
different from cytosolic G6PD. It had a different optimal pH, Km value, and metal
requirement, but still required G6P and NADP as substrate. Reasons for the presence of
G6PD in the mitochondria and the difference in physical properties were unknown.
Particulate G6PD has also been found in rat liver peroxisomes (11, 12), rat renal cortical cells (58), and rabbit liver microsomes (15). G6PD in peroxisomes was thought to produce NADPH for chain elongation of saturated fatty acids (11). Stanton et a l(58) incubated rat renal cortical cells with epidermal growth factor (EOF) or platelet derived growth factor (PDGF) and noticed a 25% and 27% increase, respectively, in G6PD activity. It was thought that the increase was due to the release of G6PD from a structural element. Since the increase was rapid, protein synthesis was ruled out as the reason for the increase in activity. Ozols (15) isolated G6PD from rabbit liver microsomes and characterized its complete amino acid sequence. The sequence was not the same as that for cytosolic G6PD and the molecular mass was much larger (90 versus
56 IcDa). There were few homologous amino acid sequences. The microsomal G6PD
2 0 was blocked by a proglutamyl residue at the N-terminus and had carbohydrate attached at residue Asn-138 and Asn-263. Treatment of the microsomal enzyme with endo H, which preferentially cleaves high mannose glycoproteins, resulted in a shift in molecular weight when analyzed by SDS-P AGE, confirming the presence of an oligosaccharide and characterizing microsomal G6PD as a glycoprotein.
Overshoot in G6PD Activity
Factors Influencing G6PD Overshoot
As mentioned previously, one of the characteristics of lipogenic enzymes is an increase in activity with carbohydrate refeeding. When animals are fasted then refed a high carbohydrate diet, there is an overshoot in G6PD activity, which could be ten times the fasted level by 72 hours (59-63). Similar overshoots have been found in experiments with acetyl CoA carboxylase (64), fatty acid synthase (65), malic enzyme
(62) and ATP-citrate lyase (64, 66) which all showed an increase in enzyme activity when a high carbohydrate diet was fed. In most experiments, the animals were fasted for at least 48 hours and refed for various times. The peak in G6PD activity occurred between 48 and 72 hours (63).
Age and gender of the animals had differing effects on G6PD activity. Young rats of two months old had a greater response to starvation-refeeding than aged rats (22 months) while middle-aged rats (about 12-18 months) were similar in overshoot activity to young rats (67-69). Female rats had a higher G6PD activity than males when fed a normal chow diet (70) perhaps due to higher levels of estrogen in female rats (71).
21 When fasted and refed a high carbohydrate diet, male rats had a greater response to
refeeding than female rats (70-72) possibly due to the higher G6PD levels in female rats
under normal conditions.
Many theories have been proposed to explain the overshoot in G6PD activity.
Since the high increase in activity occurs when an animal has been fasted and not
merely transferred from a high fat or regular chow diet to the high carbohydrate diet,
Giminez and Johnson (73) pair fed rats to see if the overshoot could be due to increased
food intake after fasting. To mimic the effects of fasting, fed rats were maintained on a
high fat diet then switched to a high carbohydrate diet. Fasted-refed rats were fasted for
48 hours then refed the high carbohydrate diet in amounts equal to that ingested by the
fed group. The investigators found that transferring the rats from fat to sucrose resulted
in only a small increase in G6PD activity while the switch to a high sucrose diet after
fasting had a 10-20-fold increase in activity. Clearly, the overshoot was not due to
increased food intake since both groups of rats ingested the same amounts. There must
be something about the starved state that caused the induction.
The effect of fat in the diet on G6PD activity has also been investigated. Some
experimenters refed a high carbohydrate diet which had no fat (4, 25, 74-76,) while
others used a high carbohydrate diet containing fat (69, 77, 78). The increase in G6PD activity occurred in both groups of rats after a period of fasting. Dror et a l(77) found that when carbohydrate in the diet was replaced by fat, enzyme activity was as low as in fasted rats. Yagil and co-workers (79) performed experiments with mouse liver. They fed rats a 40% carbohydrate/ 25% fat diet and found that when fat was removed, there
2 2 was an overshoot in G6PD activity. They found that this induction would continue
through several fat, no-fat diet cycles (79).
The carbohydrate source seems to have an effect on the overshoot in G6PD
activity. Many experimenters have seen this overshoot with refeeding a high glucose or
fructose diet (4, 63, 64, 74, 80). Fitch et al (80) showed that fructose had a greater
effect on enzyme activity than glucose. G6PD activity has also been shown to increase
when animals were refed a diet high in glycerol (81). Sucrose, however, was shown to
elicit the greatest increase in G6PD activity (61, 75, 82).
When carbohydrate is consumed it triggers a release of insulin. Insulin then
causes a response in many other cells and activates many systems, including lipogenesis
and protein synthesis. For this reason, many investigators have examined insulin's role
in the carbohydrate-mediated increase in G6PD activity. The diabetic animal model is good for studying the effects of insulin administration. In diabetic rats, insulin increased G6PD activity to levels higher than in normal rats and this increase was found to be dose-dependent (83, 84). Fitch et al (85) found that diabetic rats had less of a change in G6PD activity than normal rats when a high glucose or fhictose diet was fed.
When normal rats were fed a chow diet (83) or one with high glucose or fructose (86) and injected with insulin, there was an increase in G6PD activity. Other experiments involved isolated hepatocytes from fed or fasted rats, which were then treated with insulin. Kurtz and Wells (87) discovered that glucocorticoids were needed as well as insulin to cause an increase in G6PD activity in hepatocytes isolated from fed rats.
Others have argued that insulin does not act as a direct inducer of G6PD. Rather it acts
23 by increasing appetite, which increases carbohydrate intake (88), or it has no effect on
induction by itself (63). Rudack et al (76) have argued that insulin does not directly
regulate the level of G6PD in vivo because the amounts required to produce an
overshoot in activity are not of a physiological nature.
G6PD and Protein Synthesis
By far the most popular theory explaining the increase in G6PD activity when
fasted rats are refed a high carbohydrate diet is that protein synthesis increases the
amount of G6PD present in cells. It seems logical that if there is a substantial increase
in activity there must be a large increase in the amount of enzyme to account for that
activity. Another theory is that there is an increase in active enzyme independent of
protein synthesis. The enzyme is present in adequate amounts, but there is some
activator mechanism which causes it to become more active. Although there is much
evidence pointing to increased enzyme synthesis, the activator theory is still plausible.
The first evidence that protein synthesis was required for the overshoot in G6PD activity caused by refeeding carbohydrate was the discovery that protein was needed in the diet to reach maximum inducible G6PD activity (3, 61, 89, 90). When a high carbohydrate/ no protein diet was compared to a high carbohydrate/ low protein diet, the overshoot in G6PD activity was more pronounced in the diet containing protein.
Adequate protein would be necessary for protein synthesis because dietary protein supplies essential amino acids required for building new proteins.
24 About the same time, investigators examined the activator theory. Rat liver
cytosol from induced rats was added to cytosol from non-induced rats to see if G6PD in
non-induced rats could be activated. The rationale was that if an activator was present
in the induced rat and the cytosol was mixed with the non-induced rat's cytosol, the non-
induced G6PD would also be activated. There was no indication that a change in
activity occurred when the two were mixed indicating that the overshoot was not due to the presence of a simple activator molecule (74, 79).
Blockers to protein synthesis were examined to see if they could reduce the induction of G6PD. Potter and Ono (3) showed that the increase in activity expected when rats were refed a high carbohydrate diet can be inhibited by ionizing radiation and puromycin administration in a dose-dependent manner. Another antibiotic, actinomycin
D, is known to block the transcription of DNA to RNA, and when administered blocked the increase in G6PD activity (75). Sassoon et a l(78) found that the activity overshoot was blocked when actinomycin D was administered at the start of refeeding but not when given four hours later. In an experiment with rats trained to eat their meal in a 2 hour time period. Mack et a/ (91) found that cyclohexamide could block the expected increase in G6PD activity completely if administered at the beginning of refeeding or two hours later while actinomycin D blocked it completely if given at zero hours and mostly if given at two hours. These experiments could point to a role of protein synthesis in the overshoot in G6PD activity if mRNA synthesis is triggered shortly after feeding begins.
25 8-Azaguanine can be incorporated into EINA instead of guanine during mRNA
synthesis, which also stops protein synthesis at the translational level. Szepesi and
Freedland (92) were the first to show that 8-azaguanine prevented the overshoot in
G6PD activity but did allow the activity to return to normal fed levels following fasting.
Mack et a l(93) starved rats for seven days, refed them a protein-ffee 90% sucrose diet
for two days, and then administered a 90% protein diet. There was an increase in G6PD
activity 2-3 times that of the fed rats during the high carbohydrate diet intake which was
increased further when the high protein diet was fed, even when 8-azaguanine was given at the start of the protein diet time period. They concluded that the increase in activity with the high sucrose diet paralleled the synthesis of mRNA and did not require protein while the increase in activity on the high protein diet was independent of mRNA synthesis.
Results fi-om experiments using protein synthesis blockers can be conflicting because of the effect these blockers have on food intake and overall health of the animals (74). Puromycin, actinomycin D, and cyclohexamide decrease food intake because they can destroy the intestinal lining (92). The decrease in G6PD induction could be correlated to a decrease in food intake or nutrient absorption. These same substances can be toxic to the animal, so the time of administration of the dose is important when investigating their effects. A better method to analyze the role of protein synthesis is to measure directly the amount of enzyme or the rate of synthesis.
A technique known as immunochemical titration has been used by many investigators (2, 7, 8, 36, 88, 94-96,) to measure the amount of G6PD present in cells.
26 This method is based on antibody binding to G6PD and the complex precipitating. An
antibody to G6PD would be prepared and combined with the appropriate amount of
liver supernatant. After incubation, the samples are centrifuged. A radioactive label could be used to quantitate the antibody/enzyme complex, or the supernatants measured for remaining activity. In most cases, there was a proportional increase in immunochemical precipitation and enzyme activity in induced rats indicating that more enzyme was present to cause the overshoot in activity. This strengthens the argument for increased synthesis of enzyme. Two groups, however, did not find a difference in enzyme quantity between fed and carbohydrate-refed rats. Hizi and Yagil (7) concluded that the change in activity upon refeeding was not due to synthesis of new enzyme in mouse liver. Kelley et al (8) did not find a difference between fed and refed animals in rat liver G6PD content and concluded that an activation-inactivation mechanism must be at work.
The discrepancies in results among the researchers may be attributable to non- specificity of antibody. When antibodies were prepared against impure G6PD, non specific antibody binding resulted (29). Dao et al (97) recognized that an antibody may not react with active and inactive forms of G6PD to the same extent. They prepared a monoclonal antibody which could react with palmitoyl CoA-inactivated G6PD. When radioimmunoassay was used to detect the quantity of G6PD, there were comparable amounts in rats that were fasted and refed a high carbohydrate diet and fasted and refed a high fat diet.
27 Winberry and Holten performed experiments to measure protein synthesis using radioactive labels (4). Hepatocytes were isolated from pellet-fed and fat-free, high carbohydrate-fed rats and pulse-labeled with [^H]leucine to measure synthesis directly.
A second method involved isolating polysomes and measuring the binding of '^^I-anti glucose-6-phosphate dehydrogenase to them (4). Both methods indicated there was increased enzyme synthesis in carbohydrate-refed rats.
Once it was widely accepted that the increase in G6PD activity caused by fasting and refeeding a high carbohydrate diet was due to protein synthesis, investigations began to determine what stage of protein synthesis was regulated. It could be at the level of mRNA transcription, mRNA stability, or some post- transcriptional event. Sun and Holten used a rabbit reticulocyte lysate system and isolated RNA to measure the amount of G6PD mRNA (98). They discovered a 2-3-fold increase in the amount of mRNA coding for the enzyme in carbohydrate-refed versus fed rats which they felt was insufficient to account for the 20-fold increase in enzyme synthesis. Therefore they concluded there was some post-transcriptional element working in addition to mRNA synthesis, possibly a change in the efficiency with which the mRNA is translated. In contrast, Miksicek and Towle (5) using a slightly different method measured G6PD mRNA activity and discovered a higher concentration of mRNA in fasted/refed rats indicating an elevated mRNA level leading to increased protein synthesis. At the same time Miksicek and Towle (5) measured mRNA template activity by cell-free translation of poly(A)-containing RNA in the rabbit reticulocyte
28 lysate system and discovered an increase in template activity, which paralleled the
increase in G6PD activity.
Both of these groups used an in vitro measurement of mRNA as an indirect
measurement of mRNA levels. More recent studies to assess the transcriptional role in
protein synthesis involved hybridizing isolated mRNA to cDNA. Kletzien's group (99)
developed a cDNA probe for G6PD and discovered that there is an increase in
hybridizable mRNA in fasted-refed rats compared to normal rats. Ultimately, the
transcription rate of G6PD mRNA was measured and it was found to increase in tandem with mRNA levels and enzyme activity when rats were fed a high carbohydrate diet
(25, 39, 100). It was discovered that transcription rates reached a maximum of three fold in six hours while mRNA concentrations reached a maximum of 10 fold in 16 hours. It was felt that the combined increase in transcription rate and mRNA concentration was enough to account for the increased G6PD activity in starved-refed rats.
The next stage in the exploration of the reasons behind the overshoot in G6PD activity involved determining what was the primary inducer of the protein synthesis.
Once again the role of insulin was investigated. Since it is difficult to assess the exact role of hormones in intact animal systems, cell systems of isolated hepatocytes from rats that underwent dietary treatment were used. Insulin or dexamethasone (a synthetic glucocorticoid), and a carbohydrate source of glucose, fructose, or glycerol were added to the culture medium. Insulin alone and dexamethasone alone caused an increase in
G6PD mRNA (38, 101, 102). When both were administered, the results were additive.
29 Interestingly, dexamethasone increased the level of mRNA without causing an increase
in the rate of synthesis of G6PD. This indicated that a combination of hormones may
be necessary for full induction. Other investigators have looked at the role of glucagon
in G6PD induction. Garcia and Holten (94) discovered that glucagon prohibits the
induction of G6PD by a decrease in protein synthesis and cAMP also decreases G6PD
synthesis. Rudack et a lalso discovered that glucagon and cAMP decrease the activity
of G6PD (76) and that this effect could involve inactivation of enzyme or a decrease in
protein synthesis (103).
Other Regulatory Mechanisms for G6PD Induction
Protein synthesis is just one of the many forms of regulation that keeps an organism in homeostasis. Many enzymatic reactions are controlled by the amount of substrate or product available in a system. The amount of substrate limits the operating capacity of an enzyme. Obviously there must be substrate available for the enzyme to act. As the availability of substrate increases, the reaction rate increases until the enzyme becomes saturated and is acting at its maximum velocity (Vmax). The substrate necessary for G6PD is glucose-6-phosphate (G6P) with NADP as a cofactor.
G6P is readily available in a cell under lipogenic conditions as a metabolite of glucose, and it is possible that the increased substrate upon feeding a high carbohydrate diet could account for an increased G6PD activity. This simple hypothesis is not supported
(104). When thyroxine and estrogen were given to animals on a carbohydrate free diet, there was still an elevation in G6PD activity (105). Also, the induction was much
30 greater in rats that were fasted prior to a carbohydrate diet compared to those switched
from a high fat diet or regular chow diet. If the availability of glucose, and
consequently G6P, was the main regulator, there would be an overshoot in enzyme
activity under all conditions where a high carbohydrate diet is fed.
The immediate products of the G6PD reaction are 6-phosphoglucono lactone
and NADPH. 6-Phosphoglucono lactone is immediately changed by non-enzymatic
hydrolysis to 6-phosphogluconate. There is rarely a build-up of either 6-
phosphoglucono lactone or 6-phosphogluconate that could directly inhibit G6PD. The
ratio of NADPH/NADP, however, could have an immediate effect on G6PD activity.
Krebs and Eggleston (104, 106) have found that NADPH inhibits G6PD and believed the enzyme was actually regulated by overcoming this inhibition. Out of over a hundred substances tested in in vitro conditions, only GSSG was found to overcome the inhibition. GSSG can change the NADPH/NADP ratio through the action of glutathione reductase. NADPH is consumed in the reaction and reduced glutathione formed. Ayala et al (6, 107) have also performed experiments with NADPH/NADP ratios and discovered that an increase in consumption of NADPH caused by increased fatty acid synthesis or detoxification reactions was accompanied by an increase in
G6PD activity, but when NADPH was not consumed the enzyme activity levels did not increase. Thus, there is a regulatory role for this product.
Dietary fatty acids have been examined to determine if they play a role in the regulation of G6PD. Dietary fat has been shown to cause an 8-fold decrease in G6PD activity when rats were switched from a no-fat diet to one containing 1 5% fatty acids
31 (88). This decrease was found to coincide with a decreased food intake, however, and these researchers decided that fatty acids do not have a direct effect on G6PD activity or
synthesis (88). Other researchers have found that fatty acid consumption does decrease
G6PD activity (65, 83). Muto (65) gave fatty acids to rats adapted to a high carbohydrate/no fat diet and saw a decrease in G6PD activity. Sassoon et a l(63) found no evidence that fatty acids act as a feedback inhibitor. A direct role of fatty acids as an inhibitor of G6PD in the liver has not been established.
A common regulatory mechanism for enzyme regulation is that of covalent modification. An enzyme could be altered in such a way that it becomes more or less active. For example, acetyl CoA carboxylase undergoes phosphorylation/ dephosphorylation cycles, which alter its activity. Since acetyl CoA carboxylase and
G6PD are both lipogenic enzymes, G6PD has been investigated to see if undergoes some form of covalent modification. Thus far only one group has found that G6PD can be phosphorylated but only on tyrosine residues (108) and not serine/threonine residues as are other lipogenic enzymes (109). The researchers stated that this reaction was carried out in vitro and there is no evidence that this phosphorylation occurs physiologically. As this is the only mention of phosphorylation of G6PD, it seems unlikely that the increased activity observed upon refeeding a high carbohydrate diet is caused by this type of covalent modification.
Compartmentation of enzymes is another form of regulation. Some enzymes are active only in certain cells or cellular compartments. Since they are separated from another compartment by a membrane, their action is limited to the environment in
32 which they are present. For example, the reactions to carry out fatty acid biosynthesis take place in the cytosol while those for fatty acid oxidation occur in the mitochondria.
Although G6PD is present in all cell types, it has typically been found only in the cytosol of cells. Since the reaction catalyzed by G6PD occurs in the cytosol, it is logical that is where it is predominantly found. However, G6PD has also been found in the particulate fraction of some cells. The reason for its presence there has not been elucidated, but perhaps there is some form of regulatory mechanism that requires its presence in a particulate form.
Another type of enzyme regulation related to compartmentation is that of ambiguity. The subcellular distribution of an ambiquitous enzyme depends upon the physiological state of the organism. The enzyme can exist in more than one distinct intracellular location depending on the metabolic state of the tissue. The most characterized ambiquitous enzyme is hexokinase. Normally hexokinase is found in the cytosol where it metabolizes glucose, but many researchers have found that hexokinase is also membrane-bound on the mitochondria or microsomes (110-115). It has been shown by digitonin fractionation that hexokinase is associated with the outer mitochondrial membrane in rat kidney (111) and rat brain (112). In rat liver hepatocytes, it was shown that glucokinase (hexokinase IV) could be rapidly released from its bound form by incubation with glucose in the presence of insulin (113).
Hexokinase's mitochondrial location gives it preferred access to ATP generated by oxidative phosphorylation. When the cell needs to metabolize large amounts of glucose.
33 hexokinase is released to move closer to the cell membrane to catch glucose as it enters
the cell.
Although many of the regulatory mechanisms of G6PD have been investigated,
the subcellular distribution and possible involvement of a giycan moiety have not been
thoroughly examined. G6PD possesses many of the same characteristics as other
lipogenic enzymes in that activity is dependent on the metabolic state of the organism
and can change with dietary manipulations. Acetyl CoA carboxylase, a rate limiting
enzyme for fatty acid biosynthesis has been shown to be a glycoprotein with an
association with the outer mitochondrial membrane. This association has been shown to change in response to changes in diet and the presence of insulin. This release of
enzyme and conversion to an active form is a form of short-term regulation compared to long term regulation such as protein synthesis. Although many investigators have reported that the overshoot in G6PD activity upon refeeding a high carbohydrate diet to previously fasted animals is due to protein synthesis, other studies suggest that there are additional short-term regulatory mechanisms of this enzyme.
34 CHAPTER 2
METHODS AND MATERIALS
Bakers Yeast Studies
Separation of Cvtosol and Mitochondria
Type n Baker's yeast {Saccharomyces cerevisiae) was used to detect the presence of G6PD in mitochondria (116). Six grams of yeast were placed in 60 ml of 3- mercaptoethanol buffer (2GmM Tris-Cl, 25mM EDTA, 0.2M 3-mercaptoethanol, pH
8.0) and incubated at 30°C for 30 minutes. The yeast mixture was poured into centrifuge tubes and centrifuged at 3000 g for 10 minutes. The supernatant was discarded and the pellet washed with 60 ml 0.6M mannitol/20mM Tris-Cl, pH 7.5. The yeast was centrifuged again at 3000 g and the supernatant discarded. The pellet was suspended in 60 ml of the 0.6M mannitol buffer and the mixture equilibrated at 30°C.
Lyticase (10,OOOU) and 0.2mM PMSF were added and the yeast incubated at 30°C for
90 minutes to help degrade the outer cell membrane. The yeast cells were centrifuged at 3000 g for 10 minutes, the supernatant discarded, and the pellet washed in 60 ml of
0.3M mannitol. The centrifuge and wash steps were repeated. The supernatant was again discarded and the pellet homogenized with a Sorvall Omnimixer at high speed for
15 seconds in 60 ml of 0.3M mannitol. The homogenate was centrifuged at 700g for 20
35 minutes. The supernatant was preserved and centrifuged at 27K g for 20 minutes. The
supernatant was carefully decanted and saved (mitochondrial-free supernatant). The pellet was resuspended in 30 ml of 0.3M mannitol, centrifuged as above, and the supernatant discarded. The pellet (mitochondria) was resuspended in 5 ml of 0.3M mannitol. The cytosol and mitochondria were assayed for protein and G6PD activity and boiled in SDS-mix for polyacrylamide gel electrophoresis (PAGE).
Separation of Yeast Outer Mitochondrial Membrane and Treatment with
Phosphatidvlinositol Specific Phospholipase C
The mitochondria were separated from yeast cells as described and the final pellet resuspended in 4 ml of 0.3M mannitol. The mitochondria were assayed for protein. Recrystallized digitonin was used to separate the outer mitochondrial membrane from the mitochondria (21, 55). Digitonin was weighed at a concentration of
0.6mg digitonin/mg protein and placed in 0.3M mannitol buffer. It was dissolved by heating then cooled. The mitochondria and digitonin were mixed 1:1 to achieve the above concentration and incubated on ice for 20 minutes. The mitochondria were evenly distributed in hard-sided centrifuge tubes and centrifuged in an ultracentrifuge at
4°C at 40K g for 30 minutes. The supernatants were poured into clean tubes and the pellets discarded. The tubes were centrifuged at 4°C at 160K g for 60 minutes. The supernatant was saved and the pellets suspended in 2 ml total volume 0.3M mannitol.
The pellet contained the outer mitochondrial membrane. Both fractions were assayed for G6PD activity. The outer mitochondrial membrane had 1 mg/ml BSA added to
36 preserve enzyme activity. For phosphatidylinositol specific phospholipase c treatment,
500|ii of pellet, SOjiI of 20% non-idet P-450 detergent, and lU of phosphatidylinositol
specific phospholipase c were incubated at 37°C for 60 minutes (117). A control was
also incubated that had water substituted for the phospholipase c. After incubation, the
samples were centrifuged at 15Kgat 4°C for 10 minutes. The supernatant was saved
and the pellet suspended in 570pi of 0.3M mannitol with 0.2% non-idet. The fractions
were assayed for G6PD activity and boiled in SDS-mix for quantitative analysis.
Protein Determination
Protein was determined by the procedure of Bradford (118), which utilizes the
concept of protein-dye binding. Bovine serum albumin (BSA) was used to produce a
standard curve. The samples were read on a Coleman Junior n, model 6120
spectrophotometer at 595nm.
Preparation of SDS-Boiled Samples
Samples to be used for denaturing electrophoresis and dot-blot analysis were
denatured by boiling in a sodium dodecyl sulfate (SDS) solution composed of 3.3%
SDS and 11% sucrose with bromophenol blue as indicator (21). SDS mix was heated in
a boiling water bath and 1-2 equal volumes of sample rapidly injected into boiling SDS mix. The solution was heated for 4-6 minutes. Samples were either used immediately for electrophoresis or frozen for later analysis.
37 Polyacrylamide Gel Electrophoresis
Denaturing Gel
The denatured enzyme was subjected to SDS-PAGE analysis using a 3% (w/v) acrylamide stacking gel and a 12.5% (w/v) acrylamide separating gel. The gel compositions are shown in Table 2.1. Protein standards and purified G6PD were loaded onto the same gel. The gel was run at a current of 7.5 milliamps in buffer containing
0.4M glycine, 50mM Tris, and 1% (w/v) SDS until the gel front reached one inch from the bottom of the glass plates (119). Gels were removed and placed in a solution of
Towbin’s Buffer (25mM Tris-Cl, 192mM glycine, pH 8.8, diluted 4:1 with methanol)
(120). For protein staining, individual lanes were cut from the gel and stained in a solution of 0.6% Coomassie blue R-250, 50% methanol, and 10% acetic acid.
Non-Denaturing Gel
The non-denaturing gel was 8% (w/v) polyacrylamide with no SDS and no stacking gel (Table 2.2). Samples were prepared by suspending the enzyme in a sucrose solution with bromophenol blue as a tracking dye. The cathode buffer had 10 mM
NADP added. The gel was run at a current of 3 milliamps overnight (119). A portion of the gel was stained for protein and another portion was stained for activity. Proteins in the remainder of the gel were transferred by Western Blot onto nitrocellulose (120).
38 12.5% Separating Gel 3% Stacking Gel 30% acrylamide/0.8% BIS 6.7 ml 2.0 ml 30% acrylamide (no BIS) 10 ml — 1.5M Tris-Cl, pH 8.7 10 ml —— 1.5M Tris-Cl, pH 86.8 — 2.0 ml distilled water 13 ml 15.5 ml 20% SDS 200 til 100 til 13% ammonium persulfate 100 nl 100 til TEMED 20 til 10 til
Table 2.1 Composition of Denaturing Polyacrylamide Gels
8% Separating Gel 30% acrylamide/0.8% BIS 6.7 ml 30% acrylamide (no BIS) 3.9 ml 1.5M Tris-Cl, pH 8.7 10 ml distilled water 19.1 ml 13% ammonium persulfate 100 til TEMED 20 til
Table 2.2 Composition of Non-denaturing Polyacrylamide Gels
39 Western Blot
After PAGE, samples were transferred electrophoretically onto nitrocellolose membrane (120). The gel was placed on top of the nitrocellulose and sandwiched between two pieces of filter paper. The transfer was completed in cold Towbin’s Buffer at 0.5 amps in 3 hours. The nitrocellulose was removed and completely dried before further treatment was performed.
Antibody Detection of G6PD
The nitrocellulose membrane containing G6PD was blocked with a 5% solution of non-fat dried milk solids dissolved in IMB (Immunoblot buffer: lOmM Tris Cl, 0.15
M NaCl, pH 7.6, 0.2% Triton X-100) for one hour. The nitrocellulose was washed three times, 10 minutes each with IMB and then incubated with anti-G6PD antibody in
IMB for one hour (121). After washing, the nitrocellulose was incubated with Protein
G-peroxidase in IMB for one hour. The nitrocellulose was washed thoroughly with
IMB and the peroxidase detected with ECL reagents and exposure to X-ray film.
Manufacturer's (Amersham) instructions were followed for the use of ECL detection reagents. Briefly, Solution 1 and Solution 2 were mixed in equal amounts to give 0.125 ml ECL reagents per cm^ of membrane. The membrane was immersed in the detection reagents for one minute, wrapped in plastic wrap, and exposed to X-ray film for various short periods of time. The film was then developed.
40 Quantitative Determination of G6PD
Yeast samples were analyzed for G6PD quantity by separating the cytosol from
the mitochondria and boiling the samples in SDS-mix. Four different amounts of each
fraction were added to wells of a 12.5% SDS-PAGE gel with a 3% stacking gel along
with a G6PD standard at different concentrations. The proteins were then transferred to
nitrocellulose via Western Blotting. Rat liver samples were transferred to nitrocellulose
using a BIO-RAD Bio-Dot® Microfiltration apparatus. The mitochondrial-free
supernatant and mitochondria were separated and boiled in SDS-mix. Nitrocellulose
was wetted and placed in the apparatus which was then prepared according to the
manufacturer's instructions. Samples and standards of varying concentrations were
added to individual wells and allowed to adhere to the nitrocellulose by gravity
filtration. After rinsing with IMB and drying by vacuum filtration, the nitrocellulose
with proteins was removed from the apparatus and allowed to dry completely. G6PD
from both yeast and rat liver samples was detected using the anti-G6PD antibody
procedure.
Each gel lane or dot blot was scanned using an LKB 2222-020 Ultrascan XL
Laser Densitometer and the peak area recorded. A sample readout from the densitometer for rat liver is shown in Figure 2.1. Four distinct bands can be seen corresponding to four different wells with increasing known amounts of sample. The
G6PD standard readouts for rat liver were similar. The yeast samples and G6PD standards were added to individual wells of a gel, and their readouts would have one peak for each gel lane. For the G6PD standards, a graph was made of the peak area in
41 i.n
I.M
i.st
I.JIT I.Z T t
T'Xiltie# (n) ♦ T-JUrt : iS : 74 f-iU» : 1/2 ( : 29 lierou 1
Figure 2.1 Densitometer Readout from Rat Liver Quantitative Analysis
42 O.D. units V . the amount of G6PD in the well or blot and the linear slope of the curve calculated. A sample of a yeast standard curve is shown in Figure 2.2, and a rat liver standard curve in Figure 2.3. For the samples, the peak area in O.D units was plotted v. the amount of protein in the sample and the slope calculated. The relative amount of
G6PD/amount protein was determined by dividing the slopes:
O.D units divided by O.D. units = ng G6PD/mg protein mg protein ng G6PD
A similar analysis can be performed for activity by graphing the activity of G6PD v.
O.D. units for each sample and looking at the slopes as a comparison of activity and relative quantity.
G6PD Activity Stain of Non-denaturing Gel
After removing the gel from the electrophoresis unit, lanes were cut out and placed in 50mM Tris-Cl, pH 7.4 before being stained for G6PD activity. The gel was placed in an activity stain consisting of the Tris buffer with O.SmM glucose-6- phosphate, 0.2mMNADP, 0.1 mM magnesium acetate, 0.2mg/ml nitroblue tétrazolium, and 0. Img/ml phenazinemethylsulfate (122). The gel was stained for less than 5 minutes and destained in distilled water.
43 6.0
5.0
4.0 3 Q d 3.0
2.0
1.0 10 20 30 40 50 60 70
G6PD (ng)
Figure 2.2 Standard Curve for Yeast Studies
44 3.5
3.0
2.5 c 3 Q d 2.0
5
1.0 0.60 0.96 1.32 1.68 2.04 2.40
G6PD (ng)
Figure 2.3 Standard Curve for Rat Liver Studies
45 Giycan Chain Detection of G6PD
After electrophoresis and Western blot transfer, gels containing G6PD were
probed for carbohydrate using a periodate-digoxigenin anti-digoxigenin kit from
Boehringer Mannheim (47). The manufacturer's directions for Method B were followed
with minor modifications. Specifically, after proteins were transferred to the
nitrocellulose, the blots were washed in PBS (phosphate buffered saline—50mM
BCH2PO4, 150mM NaCl, pH 6.5) for 15 minutes. All subsequent steps in the giycan
chain analysis up to the detection step were performed in buffer which contained 0.2%
Triton X-100. Carbohydrate on the nitrocellulose was oxidized with lOmM sodium
meta-periodate in lOOmM sodium acetate buffer pH 5.5 for 20 minutes. After the
nitrocellulose was washed three times for 10 minutes each with PBS, it was incubated
with digoxigenin succinyl-e-amidocaproic acid hydrazide in lOOmM sodium acetate
buffer pH 5.5 (1:5000) for one hour. After this and all the following incubation steps, the nitrocellulose was washed in TBS (Tris buffered saline—0.05M Tris Cl, 0.15M
NaCl, pH 7.5) three times for 10 minutes each. The nitrocellulose was blocked with giycan chain blocking reagent for one hour. It was incubated with anti-digoxigenin peroxidase FAB fragments in TBS (1:2000) for one hour. The nitrocellulose was incubated with peroxidase labeled anti-peroxidase in TBS (1:2000) for one hour to amplify the signal. The nitrocellulose was incubated with Protein G-peroxidase in TBS
(1:4000) for one hour to further amplify. Finally, the nitrocellulose was washed thoroughly with TBS before the peroxidase was detected with ECL detection reagents and exposed to X-ray film as described previously.
46 Enzyme Assays
G6PD activity was measured according to Rudack el a l(76). The reaction
mixture consisted of 0.12M Tris-CI, pH 8.0 with 2mM giucose-6-phosphate, 0.9mM
NADP, and l0.4mM magnesium acetate. The cuvette had a volume of 0.7 ml and the
reaction was started by the addition of enzyme solution. The activity was measured by
following NADPH production at 340nm in a Perkin Elmer Lambda 4B UV/VIS
spectrophotometer. Activity was calculated from the slope and expressed as mU/ml enzyme where one unit (U) of enzyme produces Ipmol ofNADPH/min. All mitochondrial preparations had 0.2% non-idet P-450 detergent added.
6-Phosphogluconate dehydrogenase (6PGD) activity followed the procedure of
Dror et a l(123). The reaction mix contained 0.12M Tris-Cl, pH 8.0, 1.67mM 6- phosphogluconate, 1.7mM NADP, and 3.4mM magnesium acetate. The assay proceeded as the G6PD reaction outlined above.
Monoamine oxidase (MAO) activity was assayed by the procedure of Tabor et al. (124). The enzyme solution was added to a cuvet containing 0.9 ml of 200mM
KH2PO4, pH 7.2 and lOpM benzylamine. The reaction was monitored at 250nm in the
Perkin Elmer spectrophotometer.
Malate dehydrogenase (MDH) activity was measured by the procedure of Ochoa
(125). A pre-mix consisting of 0.25M Tris-Cl, pH 7.4, 1.5mM NADH, 7.6mM oxaloacetate, and water was prepared. Enzyme solution was added to 0.7 ml of pre-mix and the production of NAD followed at 340nm. Activity was calculated from the slope of the line.
47 Adenylate kinase (ADK) activity was measured according to Schnaitman and
Greenawalt (28). The reaction mix contained 70mM Tris-Cl, pH 8.0, 0.75 mM NADP,
15mM glucose, 10 lU hexokinase, 0.4 lU G6PD, 0.45mM KCN, 3mM ADP, and SmM
magnesium acetate. The reaction mix was allowed to sit for 5 minutes to digest all
AMP. The enzyme solution was added to 0.9 ml of the mix and the production of
NADPH followed at 340nm.
Cytochrome c oxidase was measured according to Poyton (126). The buffer
system was 40mM KH2PO4 with 0.5% TWEEN, pH 6.7. In 25 ml of buffer, 20mg of
cytochrome c and 2mg dithionite were dissolved. The enzyme was added to 1 ml of
buffer solution and the reaction monitored at 550nm.
Animal Studies
Animal Care
Male, Sprague Dawley rats weighing between 150 and 200 grams were housed in pairs in galvanized, wire mesh bottomed cages. The procedures were approved by
ILACUC. All rats had ad libitum access to a high carbohydrate diet and water for at least one week prior to the beginning of an experiment (22). The composition of the diet is described in Table 2.3. The animals were maintained on a twelve hour light/dark cycle with the light cycle being between 7pm and 7am. Food was removed from fasted rats at 7am for a period of 48 hours. For refed rats, food was removed for 48 hours and rats were refed the high carbohydrate diet beginning at 7am and continuing for the
48 Ingredient ______kg______% dry weight Dextrose 580 58 Casein 210 21 Cellufil 130 13 Vitamins' 20 2 Minerals** 40 4 Com Oil 20 2 a. Composition of the vitamin mix supplement titurated in dextrose (g/kg) : a - tocopherol (lOOIU/g) 5.0, L-ascorbic acid 45.0, choline chloride 75.0, d-calcium pantothenate 3.0, inositol 5.0, menadione 2.25, niacin 4.5, PABA (para- aminobenzoic acid) 5.0, pyridoxine HCl 1.0, riboflavin 1.0, thiamine HCl 1.0, vitamin A acetate 900.000 U/kg, calciferol (D2) 100.000 U/kg, biotin 20 mg/kg, folic acid 90 mg/kg, vitamin B12 1.35 mg/kg. b. Mineral mix US? XTV contains (g/kg); ammonium 0.57, cupric sulfate 0.48, ferric ammonium citrate 94.33, manganese sulfate 1.24, potassium iodide 0.25, sodium fluoride 3.13, calcium carbonate 68.6, calcium citrate 308.3, calcium biphosphate 112.8, magnesium carbonate 35.2, magnesium sulfate 38.3, potassium chloride 124.7, dibasic potassium phosphate 218.8, sodium chloride 77.1.
Table 2.3 Composition of Diet
49 period of time specified in each experiment. Fasted rats were housed singly with free
access to water for the duration of their fast.
Isolation of Livers
Rats were weighed prior to killing. In all experiments, fed rats were taken at the
same time as the experimental fasted or refed rats. Rats were killed by cervical
dislocation following a blow to the head. Livers were quickly removed and placed on
ice (22). Livers were weighed and 0.3M mannitol added at two times the liver weight.
Homogenization was performed with four up and down strokes of a Potter-Elvehjem
homogenizer at full speed.
Separation of Cvtosol and Mitochondria
For the separation of mitochondria, 6 ml of homogenate from each liver was
placed in a chilled centrifuge tube along with 18 ml of 0.3M mannitol (20). The tubes
were centrifuged at 700 g for 20 minutes and the supernatants poured into clean tubes.
The tubes were centrifuged at 7800 g for 20 minutes. The supernatant was discarded
and the pellet resuspended in 16 the original volume of 0.3M mannitol. The suspension
was centrifuged at 7800 g for 20 minutes. The supernatant was discarded and the pellet
resuspended in 5 ml of 0.3M mannitol. The centrifugation was repeated and the pellet
resuspended in I ml of 0.3M mannitol. The mitochondria were then assayed for protein and various enzyme activities.
50 The separation of mitochondrial-free supernatant which contained cytosol and
microsomes, was performed from the original homogenate (20). Volumes were
equalized in chilled centrifuge tubes and centrifiiged at 27,000 g for 20 minutes.
Cheesecloth was rinsed with distilled, deionized water, chilled, and placed in a filter
funnel. The supernatants from the centrifugation were poured through the cheesecloth
into individual containers kept on ice. The mitochondrial-free supernatant was analyzed
for protein and various enzyme activities.
Separation of Rat Liver Mitochondrial Fractions (Digitonin Fractionation)
The separation of outer and inner mitochondrial membranes from rat liver was performed according to Greenawalt (56) as modified by Allred and Roman-Lopez (21).
Livers were extracted from fed rats and homogenized in two times their volume of
Greenawalt's buffer (70mM sucrose, 220mM mannitol, 2mM HEPES, pH 7.4, with
O.Smg/ml BSA added just prior to use). Three more volumes of Greenawalt's buffer
(GW) were added and the homogenate poured into chilled centrifuge tubes and centrifuged at 700 g for 10 minutes. The pellet was discarded and the supernatant spun again. The pellet was discarded and the supernatant poured into clean, chilled tubes.
The cell contents were centrifuged at 7800 g for 20 minutes to separate the mitochondria. The supernatant was discarded and the pellets resuspended in 16 the original volume of GW buffer. The tubes were centrifuged at 7800 g for 20 minutes and the supernatant discarded. The pellet was resuspended in Vi the original volume of
GW buffer. The process was repeated and the pellet was resuspended in a final volume
51 of 4 ml GW buffer. The protein content of the mitochondria was determined. Digitonin was added to centrifuge tubes containing mitochondria at the following concentrations:
0, 0.05, 0.1, 0.2, 0.4, and 0.6 mg digitonin/mg mitochondrial protein. The tubes were incubated on ice for 10 minutes and centrifuged at 15Kgfbr 10 minutes. The supernatants from this spin were assayed for G6PD, adenylate kinase, malate dehydrogenase, cytochrome c oxidase, and monoamine oxidase activities to determine the location of G6PD in the mitochondria.
Separation of Outer Mitochondrial Membrane in Rat Liver
Solutions of protease inhibitors were prepared as in Table 2.4. 0.5 ml of each solution was added to 0.5 L Greenawalt's buffer (127). Livers were extracted from fed rats and homogenized in two times the volume of Greenawalt's buffer with the protease inhibitors. Two more volumes of the buffer were added and the solution poured into centrifuge tubes. The procedure was then followed as in the digitonin fractionation procedure with the final 7800 g pellet suspended in 3 ml of GW buffer with protease inhibitors. The protein content was determined and the digitonin treatment performed with 0.2mg digitonin/mg mitochondrial protein. After incubation, the mixture was centrifuged at 27K g for 20 minutes. The pellet was discarded and the supernatant poured into small, hard-sided centrifuge tubes which were centrifuged at 160Kg for one hour. The supernatant was saved and the pellet washed by rinsing four times with GW buffer with no BSA. The pellet was suspended in 2 ml of GW buffer and assayed for
G6PD activity along with the supernatant from the final spin.
52 mg volume
Soin A 1 ml ethanol PMSF 17.33 TLCK 3.6 TPCK 3.6
Soin B benzamidine 156.7 1 ml water
Soin C NaNs 100 1 ml water
Soin D 1 ml water pepstatin I.O leupeptin 1.0 trypsin inhibitor 1.0
Table 2.4 Protease Inhibitors
53 Glycogen Determination
Glycogen content was measured in frozen samples of rat liver mitochondrial-
free supernatant by the method of Roehrig and Allred (128). The mitochondrial-free
supernatant was treated with aminoglucosidase to degrade the glycogen to glucose.
Aminoglucosidase was dissolved in 50mM acetate buffer, pH 4.5 to a concentration of
~4U aminoglucosidase per assay. The reaction mixture consisted of IOO|il
aminoglucosidase solution, 400 |il water, and 10 |il of the mitochondrial-free
supernatant. The mixture was incubated at 55°C for 10 minutes. A glucose
oxidase/peroxidase capsule was dissolved in 100 ml water and 0.8 ml of o-dianisidine
solution was added. lOOjjJ of the incubated samples were added to 2 ml of glucose oxidase reagent. Samples were incubated at 37°C for 30 minutes and the absorbance read at 500nm on a Coleman spectrophotometer. A standard curve was generated using purified glucose and the amount of glucose in the samples calculated from the curve.
Enzyme Kinetic Study of Rat Liver G6PD
Mitochondrial-free supernatant was isolated from livers of fed rats (20). An enzyme activity pre-mix was made consisting of 0.12M TRIS-Cl, pH 8.0, 0.9 M NADP, and 10.4mM magnesium acetate. A 2mM G6P in TRIS-Cl solution was made and various volumes added to the pre-mix in a cuvet. TRIS was used to make the total G6P volume equal 0.1 ml. The actual G6P concentrations varied from 0 to 200^M. A 20 (il aliquot of the mitochondrial-free supernatant was added to the cuvet, mixed, and assayed for G6PD activity. The activities and G6P concentrations were used to 54 construct velocity curves and Lineweaver-Burk plots to calculate the Vmax and Km of
G6PD in rat liver.
Materials
Enzymes, substrates, and reagents were purchased from Sigma Chemical
Company, St. Louis, MO with the exception of the following: sodium dodecyl sulfate,
bromophenol blue, pre-stained protein standards, biotinylated standards, glycine, acrylamide, ammonium persulfate, TEMED, nitrocellulose membranes, and Coomassie blue were obtained from BIO-RAD, Hercules, CA ECL detection reagents were purchased from Amersham, Arlington Heights, IL. The components of the giycan detection kit, sodium meta periodate, digoxigenin succinyl-e-amidocaproic acid hydrazide, and anti-digoxigenin POD FAB fragments were obtained from Boehringer
Mannhein Biochemicals, Indianapolis, IN. Kodak XAR-2 X-ray film and developing reagents were purchased from E.G. Baldwin and Associates, Hilliard, OH. The components of the rat diet were obtained from U.S. Biomedical Corp., Cleveland, OH.
Statistics
A one-way analysis of variance (ANOVA) was performed to determine overall differences in some experiments. Differences between individual means were determined using Tukey's pair-wise comparisons. Paired t-tests were performed to determine differences in some cases. In all types of comparisons, a p-value of 0.05 was used to define differences. Statistics were done using the Minitab statistical package.
55 CHAPTERS
RESULTS AND DISCUSSION
Yeast Studies
The first of these experiments used Type II Baker's yeast, Saccaromyces cerevisiae, to determine the distribution of glucose-6-phosphate dehydrogenase between the cytosol and mitochondria. Yeast cells were homogenized as described in the methods section and the cytosol and mitochondrial fi’actions separated. Both subcellular fractions were assayed for G6PD activity and subjected to SDS-PAGE to quantitate the amount of G6PD. Table 3.1 depicts the specific activity of G6PD in yeast cells while Table 3.2 shows the quantity of G6PD in cytosol and mitochondria. The data show that a considerable amount of the G6PD activity is localized in the mitochondria although the cytosol has more than twice the specific activity as the mitochondria. The cytosol also has 2.7 times the quantity/mg protein than the mitochondria. These comparisons can easily be seen in Figure 3.1. Since the specific activity and the quantity of G6PD in yeast fractions have been measured, the activity of
G6PD per quantity could be determined for each fraction. The cytosol had 5.37 ± 0.45 mU G6PD/ug G6PD while the mitochondria had 1.20 ± 0.11 mU G6PD/ug G6PD.
Thus, the cytosolic G6PD appears to be about 4.5 times more active than the mitochondrial form. 56 cyto mito cyto/mito experiment mU/mg prot mU/mg prot 1 39.33 17.98 2.19 2 59.15 22.42 2.64 3 81.25 33.15 2.45 4 * 29.11 * 5 46.36 18.36 2.53 6 47.93 21.37 2.24
mean 54.80 23.73 2.41 SEM 7.3 2.5 0.1
" denotes missing data SEM is the standard error o f the mean
Table 3.1 Specific Activity of G6PD in Yeast
cyto mito cyto/mito experiment ug/mg prot ug/mg prot 1 2.821 1.005 2.808 2 3.422 1.213 2.821 3 0.573 0.215 2.671 4 0.526 0.316 1.664 5 1.139 0.306 3.721
mean 1.696 0.611 2.737 SEM 0.60 0.21 0.33
SEM is the standard error o f the mean
Table 3.2 Quantity of G6PD in Yeast
57 70 5.0
ok_ Q. 60 2 - 4.0 a . 15 o 50 « o O) - 3.0 E 40 CO 3 E 03 E 30 3 - 2.0 5k > 20 C Ü - 1.0 cd < 10 3 a o CO 0 0.0 Cyto Mito
Activity %%%) Quantity
Figure 3.1 Activity and Quantity of Yeast G6PD
58 Stability of Yeast G6PD
It is known that G6PD loses its in vitro activity over time. Since the quantitation procedure required that the G6PD be handled over a period of several hours or days and previous researchers have shown that some antibodies do not react with inactive enzyme (97) it was necessary to determine whether the enzyme loses its antibody reactivity as well. To assess the effect of time on G6PD activity and antibody reactivity, a time course study was performed. Purified yeast G6PD was prepared in
0.3M mannitol and incubated at 37 °C. At zero time and every ten minutes an aliquot was removed. Part was assayed for G6PD activity and part spotted onto nitrocellulose using the dot blot apparatus. The quantitation procedure was then performed to assess antibody reactivity. The results are shown in Figure 3.2. G6PD rapidly lost its activity upon heating and by 60 minutes was unable to form product. The antibody reactivity, however, remained relatively stable over time. Measuring G6PD activity must be performed quickly after isolation of cell fractions, but storage of the enzyme should not be detrimental to quantitative analysis using the yeast anti-G6PD antibody.
Glvcoprotein Analvsis of Purified Yeast G6PD
Since it was shown that G6PD has a particulate form, it was examined to determine whether it was also a glycoprotein. The first step was to measure the molecular weight of yeast G6PD. This was done by performing SDS-PAGE as described with purified yeast G6PD and biotinylated protein standards of known molecular weight. After transferring the proteins to nitrocellulose, the standards were
59 0.12 10.0
0.10 8.0
0.08 3 Quantity, a E c 0.06 3 > d o < 4.0 0.04
2.0 0.02 Activity
0.00 0.0 0 10 20 30 40 50 60 70 80
Time (mln)
Figure 3.2 Stability of Yeast G6PD
60 detected by incubation with streptavidin-peroxidase followed by ECL treatment. The
subunit molecular mass of G6PD was calculated to be 56kDa (Figure 3.3). This is the
reported molecular weight of the enzyme from a variety of microbial and mammalian
sources (15, 36, 79) and is close to the molecular weight of 57,229 calculated from the
amino acid sequence of Baker's yeast G6PD (26, 27).
The results of the glycoprotein detection for purified yeast G6PD are in Figure
3.4. Panel A shows lanes that were cut from a non-denaturing gel or from lanes
transferred to nitrocellulose from the same gel. Lane I shows one major protein band
detected by Coomassie Blue stain. Lane 2 is a G6PD activity stain that corresponds
with the anti-G6PD antibody reaction in Lane 3. Lanes 2 and 3 do show an additional
band with a much slower mobility that could be due to aggregation of molecules. Lane
4 contains proof that G6PD is a glycoprotein as shown by probing the nitrocellulose for
carbohydrate using the highly specific periodate-digoxigenin glycan detection method that labels carbohydrate. The glycoprotein stain matches the antibody reactivity and activity stain migrations. Panel B shows results from a denaturing gel followed by
Western Blot. Lane I was stained with Ponceau S which detects proteins. Lane 2 is the antibody stain and had one major band with another band of slightly faster mobility.
Lane 3 is the result of the carbohydrate detection and matches the mobility of the antibody stain. These results show that the same protein that has G6PD antibody reactivity is a glycoprotein.
61 100000 -
ta I T ry . irfL»
10000 0-00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 0.80 0.90 1.00
Relative Distance
Figure 3.3 Molecular Weight Determination of Yeast G6PD
62 B 12 3
Lane 1—Coomassie blue protein stain Lane I—Ponceau S protein stain Lane 2—G6PD activity stain Lane 2—G6PD antibody stain Lane 3—G6PD antibody stain Lane 3—Carbohydrate stain Lane 4—Carbohydrate stain
Figure 3 4 Glycoprotein Detection of Yeast G6PD
63 Figure 3.5 shows the results of a denaturing gel and Western Blot of partially
purified rat liver G6PD. Lane I was stained with Ponceau S and shows a double band
of protein. Lane 2 was reacted with anti-G6PD antibody and contains one big band.
Lane 3 is the glycoprotein detection which also exhibited double banding. Since the
antibody lane only showed one band, it is presumed that the preparation was
contaminated with another glycoprotein. As with the yeast results, this experiment
shows that rat liver G6PD is a glycoprotein. Thus, cytosolic G6PD as well as
microsomal G6PD fi-om rat liver (15) has carbohydrate attached.
Preliminary studies were performed to characterize the glycan nature of yeast
G6PD. Purified yeast G6PD was added to a Con A sepharose column, but did not bind to the column. This indicated that the glycan chain has a different carbohydrate structure which must not bind to the Con A column and perhaps is not N-linked. (44).
Treatment of G6PD with N-glycosidase F [B.C. 3.2.2.18] under the same conditions which removed the glycan chain from transferrin, failed to remove it from G6PD. Since
N-glycosidase F catalyzes the hydrolysis of asparagine-1 inked carbohydrates with no regard to glycan specificity (129), it appears that the carbohydrate is not linked to an asparagine residue on G6PD.
There is one particular class of glycoproteins that does not link the glycan chain to the protein at an asparagine residue. Proteins that have GPI anchors have part of their carboxyl terminal sequence cleaved and the pre-formed glycan chain is attached to the newly exposed a-carboxyl group (50). There is no specific amino acid requirement known for this addition. One characteristic of GPI-anchored proteins is a hydrophobic
64 F f
Lane I—Ponceau S protein stain Lane 2—G6PD antibody stain Lane 3—Carbohydrate stain
Figure 3.5 Glycoprotein Detection of Rat Liver G6PD 65 C-terminal region with hydrophilic residues interspersed in the sequence. Sequencing has shown that rat liver microsomal (15) and yeast cytosolic (27) G6PD both have a hydrophobic C-terminal region, but the sequencing was performed on isolated protein which would already have been processed and the C-terminal residues removed.
Nonetheless, there is enough evidence to investigate whether G6PD is a GPI-anchored protein.
Treatment of Yeast Mitochondria with Phosphatidyl Inositol Specific Phospholipase C
Once it was ascertained that yeast G6PD is present in the mitochondria and contained carbohydrate, it was speculated that it might be associated with the mitochondrial membrane. Isolated yeast outer mitochondrial membrane was treated with phosphatidyl inositol specific phospholipase c (PI-PLC) as described in the methods section to determine if it could be released from the membrane. After treatment, if the G6PD were cleaved, it should appear in the supernatant since it would no longer be associated with a particle. The results are shown in Figure 3.6. Both the activity and quantity of G6PD in the supernatant of PI-PLC treated mitochondrial membrane was much higher than in the control which was not treated with the cleavage enzyme. The activity was eleven times higher and the quantity five times higher in the treated samples compared to the control. Thus, G6PD was released from the mitochondria by PI-PLC which is highly specific for cleaving GPI-anchored proteins
(48). This evidence along with the detection of a glycan chain attached to cytosolic
G6PD indicates that G6PD is attached to the mitochondria via a GPI anchor in yeast.